Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $174,912
Award facts
- Contract value 100% obligated
- $174,911.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $174,911.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued without a set-aside designation, calls for the provision of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. DMS Pharmaceutical Group specializes in distributing a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical supplies to federal agencies, with notable offerings spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded on November 13, 2025, with performance extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to establish regional prime vendor contractors capable of supplying diverse pharmaceutical requirements to military healthcare facilities worldwide. The contract structure includes a 30-month base period with three 30-month option periods, enabling DLA to issue firm fixed-price delivery orders as needed to fulfill recurring medical supply demands across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DU26FEMQB?
SPE2DU26FEMQB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DU26FEMQB worth?
The government has obligated $174,912 on SPE2DU26FEMQB.
Is contract SPE2DU26FEMQB an order under another contract?
Yes. SPE2DU26FEMQB is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQB competed?
The extent of competition for SPE2DU26FEMQB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award